Ian Collins

1.0k total citations
65 papers, 638 citations indexed

About

Ian Collins is a scholar working on Oncology, Genetics and Cancer Research. According to data from OpenAlex, Ian Collins has authored 65 papers receiving a total of 638 indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Oncology, 13 papers in Genetics and 13 papers in Cancer Research. Recurrent topics in Ian Collins's work include BRCA gene mutations in cancer (12 papers), Global Cancer Incidence and Screening (12 papers) and HER2/EGFR in Cancer Research (9 papers). Ian Collins is often cited by papers focused on BRCA gene mutations in cancer (12 papers), Global Cancer Incidence and Screening (12 papers) and HER2/EGFR in Cancer Research (9 papers). Ian Collins collaborates with scholars based in Australia, United Kingdom and United States. Ian Collins's co-authors include Kelly‐Anne Phillips, John L. Hopper, Michael Friedländer, Roger L. Milne, Prue C. Weideman, R B Clague, Phyllis Butow, K Morgan, P.J. Holt and Sabry Ayad and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and Blood.

In The Last Decade

Ian Collins

60 papers receiving 619 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ian Collins Australia 14 239 203 168 133 68 65 638
Katina Robison United States 18 192 0.8× 162 0.8× 151 0.9× 452 3.4× 41 0.6× 75 1.1k
Matthew Schlumbrecht United States 19 325 1.4× 108 0.5× 112 0.7× 295 2.2× 58 0.9× 110 1.0k
Jerzy E. Tyczynski United States 15 438 1.8× 231 1.1× 150 0.9× 170 1.3× 52 0.8× 38 1.1k
C. W. E. Redman United Kingdom 22 348 1.5× 56 0.3× 132 0.8× 559 4.2× 45 0.7× 58 1.6k
Geraldine R. Vink Netherlands 17 405 1.7× 237 1.2× 56 0.3× 48 0.4× 23 0.3× 82 995
Ann K. Folkins United States 19 225 0.9× 147 0.7× 196 1.2× 832 6.3× 56 0.8× 54 1.3k
A. L. Kaplan United States 12 101 0.4× 88 0.4× 60 0.4× 105 0.8× 23 0.3× 18 467
Sheryl Ogden United States 14 162 0.7× 66 0.3× 93 0.6× 201 1.5× 18 0.3× 21 915
Nicholas D. Yeager United States 13 164 0.7× 92 0.5× 184 1.1× 93 0.7× 13 0.2× 51 587
Alan C. Winfield United States 14 272 1.1× 135 0.7× 44 0.3× 67 0.5× 53 0.8× 32 915

Countries citing papers authored by Ian Collins

Since Specialization
Citations

This map shows the geographic impact of Ian Collins's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ian Collins with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ian Collins more than expected).

Fields of papers citing papers by Ian Collins

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ian Collins. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ian Collins. The network helps show where Ian Collins may publish in the future.

Co-authorship network of co-authors of Ian Collins

This figure shows the co-authorship network connecting the top 25 collaborators of Ian Collins. A scholar is included among the top collaborators of Ian Collins based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ian Collins. Ian Collins is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Collins, Ian, John E. McDonough, Mark Buzza, et al.. (2025). Development of a virtual multidisciplinary meeting framework for less common cancers. Internal Medicine Journal. 55(2). 313–315.
2.
Klein, Oliver, Matteo S. Carlino, Michelle Brown, et al.. (2024). 282P Nivolumab and ipilimumab combination treatment in advanced intrahepatic cholangiocarcinoma and gallbladder cancer. Annals of Oncology. 35. S119–S119. 2 indexed citations
3.
Klein, Oliver, Bo Gao, Henry Chan, et al.. (2024). 998MO Nivolumab and ipilimumab combination treatment in advanced dMMR/MSI-H noncolorectal cancers: Results from the phase II MoST-CIRCUIT study. Annals of Oncology. 35. S679–S680. 1 indexed citations
4.
Lok, Sheau Wen, Richard de Boer, Laeeq Malik, et al.. (2023). Addition of endocrine therapy to dual anti-HER2 targeted therapy in initial treatment of HER2 + /HR + metastatic breast cancer. Breast Cancer Research and Treatment. 198(1). 67–74. 7 indexed citations
5.
Lok, Sheau Wen, A. Antón, Sally Baron‐Hay, et al.. (2023). Real world evidence of systemic therapy in hormone receptor positive advanced breast cancer (HR+ ABC) in Australia: ARORA Registry.. Journal of Clinical Oncology. 41(16_suppl). e13054–e13054. 1 indexed citations
6.
Mileshkin, Linda, Richard W. Tothill, David D.L. Bowtell, et al.. (2022). Uncertainty and the unmet informational needs of patients with cancer of unknown primary (CUP): a cross-sectional multi-site study. Supportive Care in Cancer. 30(10). 8217–8229. 4 indexed citations
7.
Gately, Lucy, Katharine J. Drummond, Mark Rosenthal, et al.. (2022). Beyond standard data collection – the promise and potential of BRAIN (Brain tumour Registry Australia INnovation and translation registry). BMC Cancer. 22(1). 604–604. 4 indexed citations
8.
Collins, Ian, Mathias Bressel, Phyllis Butow, et al.. (2018). The iPrevent Online Breast Cancer Risk Assessment and Risk Management Tool: Usability and Acceptability Testing. JMIR Formative Research. 2(2). e24–e24. 13 indexed citations
9.
Phillips, Kelly‐Anne, Ian Collins, Roger L. Milne, et al.. (2016). Anti-Müllerian Hormone Serum Concentrations of Women With Germline BRCA1 or BRCA2 Mutations. Obstetrical & Gynecological Survey. 71(8). 474–475. 8 indexed citations
10.
Collins, Ian, Adrian Bickerstaffe, Louise Keogh, et al.. (2016). iPrevent®: a tailored, web-based, decision support tool for breast cancer risk assessment and management. Breast Cancer Research and Treatment. 156(1). 171–182. 26 indexed citations
11.
Norman, Richard, Trisha Dunning, David M. Ashley, et al.. (2016). A Discrete Choice Experiment to Examine the Preferences of Patients With Cancer and Their Willingness to Pay for Different Types of Health Care Appointments. Journal of the National Comprehensive Cancer Network. 14(3). 311–319. 22 indexed citations
12.
Collins, Ian, G. Bruce Mann, Jon Emery, et al.. (2014). Assessing and managing breast cancer risk: Clinicians' current practice and future needs. The Breast. 23(5). 644–650. 41 indexed citations
13.
Ralph, Angelique F., Melanie L. Bell, Ian Collins, et al.. (2014). Women's preferences for selective estrogen reuptake modulators: An investigation using protection motivation theory. Patient Education and Counseling. 96(1). 106–112. 20 indexed citations
14.
Collins, Ian, Roger L. Milne, Prue C. Weideman, et al.. (2013). Preventing breast and ovarian cancers in high‐risk BRCA1 and BRCA2 mutation carriers. The Medical Journal of Australia. 199(10). 680–683. 43 indexed citations
15.
Collins, Ian, Prudence A. Francis, & Linda Mileshkin. (2012). Adjuvant trastuzumab in HER2-positive breast cancer.. New England Journal of Medicine. 366(7). 664–664. 3 indexed citations
16.
Collins, Ian, Oscar S. Breathnach, & Patrick Felle. (2012). Electronic clinical decision support systems attitudes and barriers to use in the oncology setting. Irish Journal of Medical Science (1971 -). 181(4). 521–525. 11 indexed citations
17.
Collins, Ian, et al.. (2011). Carboplatin Dosing in Ovarian Cancer. International Journal of Gynecological Cancer. 21(7). 1213–1218. 12 indexed citations
18.
Collins, Ian, Susan M. Domchek, David G. Huntsman, & Gillian Mitchell. (2011). The tubal hypothesis of ovarian cancer: caution needed. The Lancet Oncology. 12(12). 1089–1091. 24 indexed citations
19.
Collins, Ian & David M. Thomas. (2011). Novel Approaches to Treatment of Leiomyosarcomas. Current Oncology Reports. 13(4). 316–322. 6 indexed citations
20.
Collins, Ian, Siobhan Nicholson, & Kenneth J. O’Byrne. (2010). A Lung Cancer Responding to Hormonal Therapy. Journal of Thoracic Oncology. 5(5). 749–750. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Katina Robison Breakdown of academic impact, for papers by Matthew Schlumbrecht Breakdown of academic impact, for papers by Jerzy E. Tyczynski Breakdown of academic impact, for papers by C. W. E. Redman Breakdown of academic impact, for papers by Geraldine R. Vink Breakdown of academic impact, for papers by Ann K. Folkins Breakdown of academic impact, for papers by A. L. Kaplan Breakdown of academic impact, for papers by Sheryl Ogden Breakdown of academic impact, for papers by Nicholas D. Yeager Breakdown of academic impact, for papers by Alan C. Winfield
Rankless by CCL
2026